Group One Trading’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-200
Closed -$34K 5796
2018
Q3
$34K Sell
200
-1,100
-85% -$185K ﹤0.01% 4190
2018
Q2
$226K Sell
1,300
-5,900
-82% -$887K ﹤0.01% 2959
2018
Q1
$831K Sell
7,200
-14,800
-67% -$1.57M 0.01% 1655
2017
Q4
$1.85M Buy
22,000
+19,000
+633% +$1.58M 0.01% 1237
2017
Q3
$276K Hold
3,000
﹤0.01% 2528
2017
Q2
$241K Buy
+3,000
New +$166K ﹤0.01% 2511

Other funds holding LOXO

Group One Trading's LOXO Position: Q4 2018 in Review

Group One Trading sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 202 shares — an estimated $35K sold.

Group One Trading first reported a position in LOXO in Q2 2017 and held it in 5 quarters. The position peaked at $373K in Q4 2017. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

  • Group One Trading reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
  • Group One Trading sold 202 Loxo Oncology, Inc shares in Q4 2018, an estimated $35K.
  • Group One Trading first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 5 quarters.
  • Group One Trading's Loxo Oncology, Inc position peaked at $373K in Q4 2017.
  • 232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.